Jeffrey R. Marks
Reproducibility track record
1
assessed papers
67/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
15
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Mary C. Beckerle 1Stephen Piccolo 1Leigh Neumayer 1Avrum Spira 1W. Evan Johnson 1Laura Hoffman 1Adam L. Cohen 1Gajendra Shrestha 1Philip J. Moos 1Irene L. Andrulis 1
Institutions
Brigham Young University 1Boston University 1University of Utah 1Huntsman Cancer Institute 1Duke University 1Mount Sinai Hospital 1
Geography (author institutions)
US 1CA 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (611)
Request a reproduction →1 assessed by us (0 reproduced) · 610 not yet assessed — every PubMed paper on record, linked below.
-
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression ↗Cancer Cell · 2026 · PMID 41997138not yet assessed
-
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition ↗bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 42079185not yet assessed
-
Spatial proteomics of breast ductal carcinoma in situ reveal distinct regional differences ↗Scientific Reports · 2026 · PMID 41826651not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Unsupervised Domain Adaptation for Calcification Classification in Mammography Across Multi-Site Datasets ↗arXiv (Cornell University) · 2026not yet assessed
-
Unsupervised Domain Adaptation for Calcification Classification in Mammography Across Multi-Site DatasetsarXiv (Cornell University) · 2026not yet assessed
-
Extracellular Matrix Proteomic Signatures Associate with Disease-Free Survival in Later Events of Ductal Carcinoma In Situ or Invasive Breast Cancer ↗bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 42539300not yet assessed
-
Spatial localization of collagen hydroxylated proline site variation as an ancestral trait in the breast cancer microenvironment ↗Matrix Biology · 2025 · PMID 39863086not yet assessed
-
Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic–Phenotypic Relationships Altering Epithelial Composition ↗Cancer Research · 2025 · PMID 40101158not yet assessed
-
Homologous Recombination Deficiency and Survival in Ovarian High-Grade Serous Carcinoma by Self-Reported Race ↗Cancer Epidemiology Biomarkers & Prevention · 2025 · PMID 40905821not yet assessed
-
Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ ↗Radiology · 2025 · PMID 41251557not yet assessed
-
Phenotyping and clinical utility of phagocytic polyploid giant cancer macrophages in blood ↗Cancer Letters · 2025 · PMID 40912599not yet assessed
-
Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancer ↗Breast Cancer Research · 2025 · PMID 40119428not yet assessed
-
Comorbid conditions and survival among Black women with ovarian cancer ↗Cancer · 2025 · PMID 39748467not yet assessed
-
Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals ↗Cancer Research · 2025 · PMID 40063699not yet assessed
-
Mapping the temporal landscape of breast cancer using epigenetic entropy ↗Communications Biology · 2025 · PMID 41102398not yet assessed
-
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study ↗Annals of Surgical Oncology · 2025 · PMID 40715630not yet assessed
-
Homologous Recombination Deficiency in Ovarian High-Grade Serous Carcinoma by Self-Reported Race ↗SSRN Electronic Journal · 2025not yet assessed
-
Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race ↗medRxiv · 2025 · PMID 39974072not yet assessed
-
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer ↗medRxiv · 2025 · PMID 39974026not yet assessed
-
Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance) ↗Breast Cancer Research · 2025 · PMID 39980051not yet assessed
-
Abstract 4927: Tumor tissue microbiome in the high-grade serous ovarian cancer: a pilot investigation within the African American Cancer Epidemiology Study ↗Cancer Research · 2025not yet assessed
-
Abstract 3353: Predicting the prognosis of ductal carcinoma in situ through chemical analysis of breast microcalcifications and soft tissue using infrared and Raman spectroscopy ↗Cancer Research · 2025not yet assessed
-
Abstract 7482: Mapping the temporal landscape of breast cancer using epigenetic entropy ↗Cancer Research · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract P1-02-30: A Stromal Proteomic Investigation of the RAHBT Cohort: Collagen Molecular Patterns Link to Recurrence in Ductal Carcinoma in Situ ↗Clinical Cancer Research · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
An Analytic Pipeline to Obtain Reliable Genetic Ancestry Estimates from Tumor-Derived RNA Sequencing Data ↗Cancer Epidemiology Biomarkers & Prevention · 2025 · PMID 40622249not yet assessed
-
Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma ↗Clinical Epigenetics · 2025 · PMID 40734190not yet assessed
-
not yet assessed
-
not yet assessed
-
ASO Visual Abstract: Patient-Reported Outcomes After Routine Treatment of In-Situ/Atypical Lesions: The PORTAL Study ↗Annals of Surgical Oncology · 2025 · PMID 40853627not yet assessed
-
Correction: Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome ↗Breast Cancer Research · 2025 · PMID 40859290not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer ↗Oncogene · 2025 · PMID 40913145not yet assessed
-
Expression of Concern for JAK2-binding long noncoding RNA promotes breast cancer brain metastasis ↗Journal of Clinical Investigation · 2025 · PMID 41031879not yet assessed
-
Spatially Discontinuous Mutation Topographies in Ductal Carcinoma In Situ Reveal Noncompetitive Growth Dynamics ↗Cancer Research · 2025 · PMID 41066536not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Use of non-prescription analgesic medications and survival among Black women with ovarian cancer ↗British Journal of Cancer · 2025 · PMID 41193853not yet assessed
-
Aggressive Neuroblastomas Start Growing after Infancy ↗bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 41889813not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ ↗JAMA · 2024 · PMID 39665585not yet assessed
-
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions ↗The American Journal of Human Genetics · 2024 · PMID 38723632not yet assessed
-
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ ↗JAMA Oncology · 2024 · PMID 39665588not yet assessed
-
Classification performance bias between training and test sets in a limited mammography dataset ↗PLoS ONE · 2024 · PMID 38324545not yet assessed
-
Extracellular Microenvironment Alterations in Ductal Carcinoma In Situ and Invasive Breast Cancer Pathologies by Multiplexed Spatial Proteomics ↗International Journal of Molecular Sciences · 2024 · PMID 38928454not yet assessed
-
Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms ↗Cancer Epidemiology Biomarkers & Prevention · 2024 · PMID 38780898not yet assessed
-
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome ↗Breast Cancer Research · 2024 · PMID 39223670not yet assessed
-
The role of multiple mediation with contextual neighborhood measures in ovarian cancer survival ↗Annals of Epidemiology · 2024 · PMID 39389398not yet assessed
-
Abstract 4829: Pre-diagnostic comorbid conditions and survival among black women with ovarian cancer ↗Cancer Research · 2024not yet assessed
-
not yet assessed
-
Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast Cancer ↗medRxiv · 2024 · PMID 39185534not yet assessed
-
Mapping the Temporal Landscape of Breast Cancer Using Epigenetic Entropy ↗Research Square · 2024 · PMID 39574883not yet assessed
-
Abstract A038: Evaluating DCIS progression: A comparative analysis of CNA predictive power derived from lpWGS and WES data ↗Cancer Research · 2024not yet assessed
-
Abstract 6929: Inter- and intratumoral PIK3CA subclonal diversity in breast cancer contextualized by single-cell multiomics ↗Cancer Research · 2024not yet assessed
-
Abstract 6127: Characterization of germline and somatic homologous recombination deficiency features in high-grade serous ovarian cancer among Black individuals ↗Cancer Research · 2024not yet assessed
-
Abstract PO4-13-04: Added Value from Patient Advocates in a Translational Working Group: the COMET Study ↗Cancer Research · 2024not yet assessed
-
The Role of Multiple Mediation with Contextual Neighborhood Measures in Ovarian Cancer Survival ↗SSRN Electronic Journal · 2024not yet assessed
-
Polyploid circulating stromal cells in blood to identify invasive solid tumors and to prognosticate for highly aggressive cancer subtypes. ↗Journal of Clinical Oncology · 2024not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract C003: Multimodal and multiplexed spatial regulation of the breast collagen proteome: Comparative analysis in Black and White women from normal breast tissue and triple-negative breast cancer ↗Cancer Epidemiology Biomarkers & Prevention · 2024not yet assessed
-
Mapping the Temporal Landscape of Breast Cancer Using Epigenetic Entropy ↗bioRxiv (Cold Spring Harbor Laboratory) · 2024not yet assessed
-
Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion ↗Science Advances · 2023 · PMID 36724291not yet assessed
-
Archival single-cell genomics reveals persistent subclones during DCIS progression ↗Cell · 2023 · PMID 37586362not yet assessed
-
Microcalcification crystallography as a potential marker of DCIS recurrence ↗Scientific Reports · 2023 · PMID 37291276not yet assessed
-
Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women ↗British Journal of Cancer · 2023 · PMID 37537254not yet assessed
-
Ipsilateral Lesion Detection Refinement for Tomosynthesis ↗IEEE Transactions on Medical Imaging · 2023 · PMID 37227903not yet assessed
-
Deprivation and segregation in ovarian cancer survival among African American women: a mediation analysis ↗Annals of Epidemiology · 2023 · PMID 37423270not yet assessed
-
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts ↗Cancer Cell · 2023 · PMID 37433282not yet assessed
-
The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women ↗Cancers · 2023 · PMID 37835542not yet assessed
-
Author Correction: The repertoire of mutational signatures in human cancer ↗Nature · 2023 · PMID 36697836not yet assessed
-
Author Correction: The evolutionary history of 2,658 cancers ↗Nature · 2023 · PMID 36697833not yet assessed
-
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing ↗Nature Genetics · 2023 · PMID 36944733not yet assessed
-
Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37873488not yet assessed
-
Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37961178not yet assessed
-
Classification performance bias between training and test sets in a limited mammography dataset ↗medRxiv · 2023 · PMID 36865183not yet assessed
-
Author Correction: The landscape of viral associations in human cancers ↗Nature Genetics · 2023 · PMID 36944734not yet assessed
-
Single Cell Expression Analysis of Ductal Carcinoma in Situ Identifies Complex Genotypic-Phenotypic Relationships Altering Epithelial Composition ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 39386437not yet assessed
-
Abstract P1-07-02: Using clinical characteristics and molecular markers to predict the risk of subsequent ipsilateral breast events after excision of DCIS ↗Cancer Research · 2023not yet assessed
-
Abstract P2-21-03: Unique Collagen Peptide Signatures between Ductal Carcinoma in Situ and Invasive Breast Cancer by Mass Spectrometry Tissue Imaging ↗Cancer Research · 2023not yet assessed
-
Abstract P4-02-22: Breast microcalcification chemistry predicts DCIS prognosis ↗Cancer Research · 2023not yet assessed
-
Abstract P6-04-13: Centralized adequacy assessment of ductal carcinoma in situ samples for the COMET study (AFT-25) ↗Cancer Research · 2023not yet assessed
-
Supplementary Data from Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer ↗2023not yet assessed
-
not yet assessed
-
Supplementary Data from Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer ↗2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 5933: Trimodal molecular analysis in single cells of a primary breast cancer cohort with ResolveOME ™ amplification ↗Cancer Research · 2023not yet assessed
-
Abstract 3506: High-grade serous ovarian cancer somatic mutational signatures in Black and White individuals ↗Cancer Research · 2023not yet assessed
-
Abstract 125: Archival single cell sequencing reveals persistent subclones over years to decades of DCIS progression ↗Cancer Research · 2023not yet assessed
-
Deprivation and Segregation in Ovarian Cancer Survival Among African American Women: A Mediated Analysis ↗SSRN Electronic Journal · 2023not yet assessed
-
From the lab to the clinic: Lessons learned from a translational working group. ↗Journal of Clinical Oncology · 2023not yet assessed
-
Abstract 5561: Molecular imaging of calcification and soft tissue defines prognosis of DCIS to invasive breast cancer ↗Cancer Research · 2023not yet assessed
-
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma ↗Cell · 2022 · PMID 35063072not yet assessed
-
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer ↗Nature Genetics · 2022 · PMID 35681052not yet assessed
-
MITI minimum information guidelines for highly multiplexed tissue images ↗Nature Methods · 2022 · PMID 35277708not yet assessed
-
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts ↗Cancer Cell · 2022 · PMID 36400020not yet assessed
-
Polygenic risk modeling for prediction of epithelial ovarian cancer risk ↗European Journal of Human Genetics · 2022 · PMID 35027648not yet assessed
-
Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features ↗Radiology · 2022 · PMID 34981975not yet assessed
-
Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES) ↗Cancer Causes & Control · 2022 · PMID 36520244not yet assessed
-
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma ↗Cancer Epidemiology Biomarkers & Prevention · 2022 · PMID 35244678not yet assessed
-
Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ ↗npj Breast Cancer · 2022 · PMID 36109587not yet assessed
-
A multi-modal exploration of heterogeneous physico–chemical properties of DCIS breast microcalcifications ↗The Analyst · 2022 · PMID 35311860not yet assessed
-
DCIS AI-TIL: Ductal Carcinoma In Situ Tumour Infiltrating Lymphocyte Scoring Using Artificial Intelligence ↗Lecture notes in computer science · 2022not yet assessed
-
Automated Dcis Identification From Multiplex Immunohistochemistry Using Generative Adversarial Networks ↗2022 IEEE 19th International Symposium on Biomedical Imaging (ISBI) · 2022not yet assessed
-
Unifying comprehensive genomics and transcriptomics in individual cells to illuminate oncogenic and drug resistance mechanisms ↗bioRxiv (Cold Spring Harbor Laboratory) · 2022not yet assessed
-
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk ↗European Journal of Human Genetics · 2022 · PMID 35314806not yet assessed
-
Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American Cancer Epidemiology Study (AACES) ↗Research Square · 2022not yet assessed
-
Abstract GS4-07: The Breast PreCancer Atlas DCIS genomic signatures define biology and correlate with clinical outcomes: An analysis of TBCRC 038 and RAHBT cohorts ↗Cancer Research · 2022not yet assessed
-
Abstract PO-232: Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma ↗Cancer Epidemiology Biomarkers & Prevention · 2022not yet assessed
-
Abstract P2-08-07: Predicting DCIS prognosis using infrared and raman spectroscopy of breast calcifications and soft-tissue microstructure ↗Cancer Research · 2022not yet assessed
-
Abstract P1-22-05: Identifying predictors of invasive recurrence based on molecular profiles of DCIS lesions ↗Cancer Research · 2022not yet assessed
-
Diverse breast adipose stromal cell biology in women at high risk for developing breast cancer ↗Research Square · 2022not yet assessed
-
Abstract 3380: Seven autoantibody panel, validated in two independent patient serum collections, can detect women with DCIS and invasive breast cancer ↗Cancer Research · 2022not yet assessed
-
Abstract 5108: Copy number analysis of pure DCIS and association with recurrence ↗Cancer Research · 2022not yet assessed
-
Abstract B019: Discrete regulation of the collagen proteome among pathological features in DCIS and invasive breast cancer by mass spectrometry tissue imaging ↗Cancer Prevention Research · 2022not yet assessed
-
Abstract PR002: Genomic predictor can discriminate between high- and low-risk DCIS ↗Cancer Prevention Research · 2022not yet assessed
-
Abstract PR010: Characterizing N-glycan profiles of DCIS progression using tissue imaging MALDI mass spectrometry ↗Cancer Prevention Research · 2022not yet assessed
-
Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower ↗Nature Communications · 2022 · PMID 36481739not yet assessed
-
Deprivation and Segregation in Ovarian cancer survival among African American Women: a mediated analysis ↗medRxiv · 2022not yet assessed
-
Unmasking the immune microecology of ductal carcinoma in situ with deep learning ↗npj Breast Cancer · 2021 · PMID 33649333not yet assessed
-
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients ↗npj Breast Cancer · 2021 · PMID 33976232not yet assessed
-
A new method to accurately identify single nucleotide variants using small FFPE breast samples ↗Briefings in Bioinformatics · 2021 · PMID 34117742not yet assessed
-
Retina-Match: Ipsilateral Mammography Lesion Matching in a Single Shot Detection Pipeline ↗Lecture notes in computer science · 2021not yet assessed
-
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men. ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2021not yet assessed
-
DCIS genomic signatures define biology and clinical outcome: Human Tumor Atlas Network (HTAN) analysis of TBCRC 038 and RAHBT cohorts ↗bioRxiv (Cold Spring Harbor Laboratory) · 2021not yet assessed
-
Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ ↗medRxiv · 2021not yet assessed
-
The Human Tumor Atlas Network (HTAN) Breast Precancer Atlas: A Multi-Omic Integrative Analysis of Ductal Carcinoma in situ With Clinical Outcomes ↗SSRN Electronic Journal · 2021not yet assessed
-
Patterns of somatic structural variation in human cancer genomes ↗Nature · 2020 · PMID 32025012not yet assessed
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing ↗Nature Genetics · 2020 · PMID 32025003not yet assessed
-
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution ↗Cell · 2020 · PMID 32302568not yet assessed
-
Genomic basis for RNA alterations in cancer ↗Nature · 2020 · PMID 32025019not yet assessed
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns ↗Nature Communications · 2020 · PMID 32024849not yet assessed
-
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis ↗Communications Biology · 2020 · PMID 32024996not yet assessed
-
Divergent mutational processes distinguish hypoxic and normoxic tumours ↗Nature Communications · 2020 · PMID 32024819not yet assessed
-
Genomic footprints of activated telomere maintenance mechanisms in cancer ↗Nature Communications · 2020 · PMID 32024817not yet assessed
-
Sex differences in oncogenic mutational processes ↗Nature Communications · 2020 · PMID 32859912not yet assessed
-
Pathway and network analysis of more than 2500 whole cancer genomes ↗Nature Communications · 2020 · PMID 32024854not yet assessed
-
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations ↗Nature Communications · 2020 · PMID 32024823not yet assessed
-
RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence ↗Cell Death and Differentiation · 2020 · PMID 31988496not yet assessed
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples ↗Nature Communications · 2020 · PMID 32958763not yet assessed
-
Minimal barriers to invasion during human colorectal tumor growth ↗Nature Communications · 2020 · PMID 32152322not yet assessed
-
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer ↗npj Breast Cancer · 2020 · PMID 32025567not yet assessed
-
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance) ↗Journal of Clinical Oncology · 2020 · PMID 32125937not yet assessed
-
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020not yet assessed
-
A multitask deep learning method in simultaneously predicting occult invasive disease in ductal carcinoma in-situ and segmenting microcalcifications in mammography ↗Medical Imaging 2020: Computer-Aided Diagnosis · 2020not yet assessed
-
Microcalcification localization and cluster detection using unsupervised convolutional autoencoders and structural similarity index ↗Medical Imaging 2020: Computer-Aided Diagnosis · 2020not yet assessed
-
not yet assessed
-
not yet assessed
-
Circulating stromal cells as a potential blood-based biomarker for screening invasive solid tumors. ↗Journal of Clinical Oncology · 2020not yet assessed
-
Metadata record for the manuscript: Unmasking the immune microecology of ductal carcinoma in situ with deep learning ↗Figshare · 2020not yet assessed
-
Abstract P1-06-02: Characterization of gene- and sample-level APOBEC mutagenesis enrichment with respect to intrinsic subtypes, tumor mutational burden, and immune composition in breast cancer ↗Cancer Research · 2020not yet assessed
-
Abstract P2-10-18: Deciphering racial disparities in breast cancer collagen reorganization by targeted extracellular matrix proteomics ↗Cancer Research · 2020not yet assessed
-
Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer ↗Cancer Research · 2020not yet assessed
-
Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer. ↗Journal of Clinical Oncology · 2020not yet assessed
-
Abstract 2502: Genetic and functional heterogeneity of DCIS as predictors of invasive cancer ↗Cancer Research · 2020not yet assessed
-
Abstract 2683: Ductal carcinoma in situ is a multiclonal disease ↗Cancer Research · 2020not yet assessed
-
A new method to accurately identify single nucleotide variants using small FFPE breast samples ↗bioRxiv (Cold Spring Harbor Laboratory) · 2020not yet assessed
-
Abstract PR02: Inferring the evolutionary dynamics of ductal carcinoma in situ through multi-regional sequencing and mathematical modeling ↗Cancer Research · 2020not yet assessed
-
Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020not yet assessed
-
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
The Immune Landscape of Cancer ↗Immunity · 2019not yet assessed
-
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression ↗Nature Immunology · 2019 · PMID 31160797not yet assessed
-
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer ↗Cell Reports · 2019 · PMID 31644911not yet assessed
-
LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition ↗Cell Research · 2019 · PMID 30631154not yet assessed
-
Association of distant recurrence‐free survival with algorithmically extracted MRI characteristics in breast cancer ↗Journal of Magnetic Resonance Imaging · 2019 · PMID 30672045not yet assessed
-
Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation ↗IEEE Transactions on Biomedical Engineering · 2019 · PMID 31502960not yet assessed
-
Multiview mammographic mass detection based on a single shot detection system ↗Medical Imaging 2019: Computer-Aided Diagnosis · 2019not yet assessed
-
Malignant microcalcification clusters detection using unsupervised deep autoencoders ↗Medical Imaging 2019: Computer-Aided Diagnosis · 2019not yet assessed
-
Synthesis and texture manipulation of screening mammograms using conditional generative adversarial network ↗Medical Imaging 2019: Computer-Aided Diagnosis · 2019not yet assessed
-
Minimal Barriers to Invasion During Human Colorectal Tumor Growth ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
Unmasking the tissue microecology of ductal carcinoma in situ with deep learning ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2019not yet assessed
-
Oncogenic Signaling Pathways in The Cancer Genome Atlas ↗Cell · 2018 · PMID 29625050not yet assessed
-
Comprehensive Characterization of Cancer Driver Genes and Mutations ↗Cell · 2018 · PMID 29625053not yet assessed
-
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation ↗Cell · 2018 · PMID 29625051not yet assessed
-
Genomic and Functional Approaches to Understanding Cancer Aneuploidy ↗Cancer Cell · 2018 · PMID 29622463not yet assessed
-
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients ↗Cancer Cell · 2018 · PMID 30078747not yet assessed
-
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines ↗Cell Systems · 2018 · PMID 29596782not yet assessed
-
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma ↗Cell Reports · 2018 · PMID 29617669not yet assessed
-
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers ↗Cell Reports · 2018 · PMID 29617662not yet assessed
-
not yet assessed
-
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer ↗Cancer Cell · 2018 · PMID 29622465not yet assessed
-
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types ↗Cell Reports · 2018 · PMID 29617667not yet assessed
-
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas ↗Cell Systems · 2018 · PMID 29596783not yet assessed
-
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas ↗Cell Reports · 2018 · PMID 29617660not yet assessed
-
Systematic Analysis of Splice-Site-Creating Mutations in Cancer ↗Cell Reports · 2018 · PMID 29617666not yet assessed
-
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set ↗Breast Cancer Research and Treatment · 2018 · PMID 30328048not yet assessed
-
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas ↗Cell Reports · 2018 · PMID 29617658not yet assessed
-
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis ↗Cancer Letters · 2018 · PMID 29803789not yet assessed
-
LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling ↗Molecular Cell · 2018 · PMID 30220561not yet assessed
-
Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features ↗Journal of the American College of Radiology · 2018 · PMID 29398498not yet assessed
-
Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer ↗Cancer Research · 2018 · PMID 29967256not yet assessed
-
LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling ↗Molecular Cell · 2018not yet assessed
-
Learning better deep features for the prediction of occult invasive disease in ductal carcinoma in situ through transfer learning ↗Medical Imaging 2018: Computer-Aided Diagnosis · 2018not yet assessed
-
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival ↗Breast Cancer Research and Treatment · 2018 · PMID 29992418not yet assessed
-
Improving classification with forced labeling of other related classes: application to prediction of upstaged ductal carcinoma in situ using mammographic features ↗Medical Imaging 2018: Computer-Aided Diagnosis · 2018not yet assessed
-
Abstract 2631: Cancer associated macrophage-like (CAMLs) cells in blood predict progression and survival for all stages of solid tumors ↗Cancer Research · 2018not yet assessed
-
Abstract 5318: High-grade serous ovarian cancer DNA methylation and survival in African-American women ↗Cancer Research · 2018not yet assessed
-
The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors ↗Nature Cell Biology · 2017 · PMID 28218907not yet assessed
-
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis ↗Journal of Clinical Investigation · 2017 · PMID 29130936not yet assessed
-
LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism ↗The EMBO Journal · 2017 · PMID 28963395not yet assessed
-
Glycosylation of KEAP1 links nutrient sensing to redox stress signaling ↗The EMBO Journal · 2017 · PMID 28663241not yet assessed
-
Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset ↗Breast Cancer Research and Treatment · 2017 · PMID 28064383not yet assessed
-
Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer? ↗Journal of Magnetic Resonance Imaging · 2017 · PMID 28181348not yet assessed
-
Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features? ↗Academic Radiology · 2017 · PMID 28506510not yet assessed
-
Prediction of occult invasive disease in ductal carcinoma in situ using computer-extracted mammographic features ↗Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2017not yet assessed
-
Can upstaging of ductal carcinoma in situ be predicted at biopsy by histologic and mammographic features? ↗Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2017not yet assessed
-
Cancer-associated macrophage-like cells as prognostic indicators of overall survival in a variety of solid malignancies. ↗Journal of Clinical Oncology · 2017not yet assessed
-
Abstract 3798: Multiplex phenotyping of circulating cancer associated macrophage-like cells in patients with solid tumors ↗Cancer Research · 2017not yet assessed
-
Can BI-RADS features on mammography be used as a surrogate for expensive genomic testing in breast cancer patients? ↗Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2017not yet assessed
-
Abstract 778: Identifying, subtyping and classifying tumor associated circulating endothelial cells in patients with solid tumors ↗Cancer Research · 2017not yet assessed
-
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS ↗Journal of Medical Genetics · 2016 · PMID 27595995not yet assessed
-
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions ↗Cancer Epidemiology Biomarkers & Prevention · 2016 · PMID 27197300not yet assessed
-
Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibilityMolecular Systems Biology · 2016 · PMID 26969729L1 67/100
-
Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women ↗Cancer Research · 2016not yet assessed
-
New software for detecting somatic mutations at low level in Sanger sequencing traces ↗European Journal of Cancer · 2016not yet assessed
-
Exploring the effect of tacrolimus on the renal kinome: identification of novel phosphoproteinsUCL Discovery (University College London) · 2016not yet assessed
-
Circulating cancer associated macrophage-like cells in the detection of invasive breast cancer. ↗Journal of Clinical Oncology · 2016not yet assessed
-
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer ↗Cell · 2015 · PMID 26451490not yet assessed
-
Digital PCR Modeling for Maximal Sensitivity, Dynamic Range and Measurement Precision ↗PLoS ONE · 2015 · PMID 25806524not yet assessed
-
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma ↗Gynecologic Oncology · 2015 · PMID 26260910not yet assessed
-
Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis ↗JNCI Journal of the National Cancer Institute · 2015 · PMID 26683405not yet assessed
-
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion ↗Breast Cancer Research · 2015 · PMID 26384318not yet assessed
-
Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer ↗Carcinogenesis · 2015 · PMID 26424751not yet assessed
-
Early detection of breast cancer using a unique tumor specific antibody. ↗Journal of Clinical Oncology · 2015not yet assessed
-
Abstract P4-02-05: A blinded multicenter phase II study of a panel of plasma biomarkers for the detection of triple negative breast cancer ↗Cancer Research · 2015not yet assessed
-
Abstract 1570: Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers ↗Cancer Research · 2015not yet assessed
-
Abstract 5165: Cancer associated macrophage-like cells as a blood-based biomarker for the screening of solid tumors ↗Cancer Research · 2015not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
A joint analysis of metabolomics and genetics of breast cancer ↗Breast Cancer Research · 2014 · PMID 25091696not yet assessed
-
Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease ↗Cancer Epidemiology Biomarkers & Prevention · 2014 · PMID 25471344not yet assessed
-
Abstract 4570: Role of ERRalpha in ovarian cancer ↗Cancer Research · 2014not yet assessed
-
Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors ↗Cancer Epidemiology Biomarkers & Prevention · 2013 · PMID 23917454not yet assessed
-
Oxidatively modified proteins as plasma biomarkers in breast cancer ↗Cancer Biomarkers · 2013 · PMID 23912491not yet assessed
-
Refining the role of BRCA1 in combating oxidative stress ↗Breast Cancer Research · 2013 · PMID 24314328not yet assessed
-
Prognostic significance of differential expression of angiogenic genes in women with invasive high-grade serous ovarian carcinoma. ↗Journal of Clinical Oncology · 2013not yet assessed
-
Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women ↗Gynecologic Oncology · 2012 · PMID 23262379not yet assessed
-
Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues ↗Gynecologic Oncology · 2012 · PMID 23274563not yet assessed
-
Abstract 3210: Glutamine synthetase is a genetic determinant of cell-type specific glutamine independence in breast epithelia ↗Cancer Research · 2012not yet assessed
-
Abstract P4-13-06: Association of Age, Obesity and Incident Breast Cancer Phenotypes ↗Cancer Research · 2012not yet assessed
-
Frequency of the cancer genome atlas expression subtypes differs between early and advanced stage high grade serous ovarian cancers ↗Gynecologic Oncology · 2012not yet assessed
-
Clinical translation of the cancer genome atlas signature for ovarian cancer survival ↗Gynecologic Oncology · 2012not yet assessed
-
Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia ↗PLoS Genetics · 2011 · PMID 21852960not yet assessed
-
Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence ↗Cancer Research · 2011 · PMID 21825015not yet assessed
-
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy ↗Biochemical Pharmacology · 2011 · PMID 21501600not yet assessed
-
Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers ↗International Journal of Gynecological Cancer · 2011 · PMID 22193641not yet assessed
-
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes ↗Breast Cancer Research · 2011 · PMID 21672245not yet assessed
-
Regulator of G Protein Signaling 5 Is Highly Expressed in Parathyroid Tumors and Inhibits Signaling by the Calcium-Sensing Receptor ↗Molecular Endocrinology · 2011 · PMID 21393447not yet assessed
-
Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES Is Consistently Increased ↗Cancer Epidemiology Biomarkers & Prevention · 2011 · PMID 21586622not yet assessed
-
Retraction Note: Genomic signatures to guide the use of chemotherapeutics ↗Nature Medicine · 2011 · PMID 21217686not yet assessed
-
Loss of ARID1A is a frequent event in clear cell and endometrioid ovarian cancers ↗Gynecologic Oncology · 2011not yet assessed
-
Abstract 3182: PTM ELISA microarray for breast cancer biomarker discovery ↗Cancer Research · 2011not yet assessed
-
Development of a Multimarker Assay for Early Detection of Ovarian Cancer ↗Journal of Clinical Oncology · 2010 · PMID 20368574not yet assessed
-
Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer ↗Journal of Proteome Research · 2010 · PMID 20977275not yet assessed
-
Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up ↗Journal of the American College of Surgeons · 2010 · PMID 20421053not yet assessed
-
Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer ↗PLoS ONE · 2010 · PMID 20386703not yet assessed
-
Urinary Biomarkers of Oxidative Status in a Clinical Model of Oxidative Assault ↗Cancer Epidemiology Biomarkers & Prevention · 2010 · PMID 20501773not yet assessed
-
Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients ↗International Journal of Cancer · 2010 · PMID 20473856not yet assessed
-
Expression signatures of TP53 mutations in serous ovarian cancers ↗BMC Cancer · 2010 · PMID 20504346not yet assessed
-
Severe Obesity Is Associated with Symptomatic Presentation, Higher Parathyroid Hormone Levels, and Increased Gland Weight in Primary Hyperparathyroidism ↗The Journal of Clinical Endocrinology & Metabolism · 2010 · PMID 20685860not yet assessed
-
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity ↗Cancer · 2010 · PMID 21254049not yet assessed
-
Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium ↗Cancer Epidemiology Biomarkers & Prevention · 2010 · PMID 20142253not yet assessed
-
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis ↗Breast Cancer Research and Treatment · 2010 · PMID 20309627not yet assessed
-
An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity ↗Clinical Cancer Research · 2010 · PMID 20179231not yet assessed
-
Individual responses to chemotherapy-induced oxidative stress ↗Breast Cancer Research and Treatment · 2010 · PMID 20830514not yet assessed
-
Calcium-Sensing Receptor Abdundance Does Not Correlate with in Vitro PTH Kinetics in to Calcium Stimulation ↗Journal of Surgical Research · 2010not yet assessed
-
Role of Eotaxin-1 Signaling in Ovarian Cancer ↗Clinical Cancer Research · 2009 · PMID 19351767not yet assessed
-
Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype ↗Gynecologic Oncology · 2009 · PMID 20006900not yet assessed
-
Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer ↗Cancer Research · 2009 · PMID 19276375not yet assessed
-
Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome ↗Clinical Cancer Research · 2009 · PMID 19318476not yet assessed
-
Comparative Genome-Wide Screening Identifies a Conserved Doxorubicin Repair Network That Is Diploid Specific in Saccharomyces cerevisiae ↗PLoS ONE · 2009 · PMID 19503795not yet assessed
-
Do serum biomarkers really measure breast cancer? ↗BMC Cancer · 2009 · PMID 19476629not yet assessed
-
Inactivation of the MAL Gene in Breast Cancer Is a Common Event That Predicts Benefit from Adjuvant Chemotherapy ↗Molecular Cancer Research · 2009 · PMID 19208741not yet assessed
-
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care ↗Breast Cancer Research and Treatment · 2009 · PMID 19224362not yet assessed
-
Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration ↗Biomarkers · 2009 · PMID 19476408not yet assessed
-
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas ↗International Journal of Cancer · 2009 · PMID 19626700not yet assessed
-
Predictors of Variation in Serum IGFI and IGFBP3 Levels in Healthy African American and White Men ↗Journal of the National Medical Association · 2009 · PMID 19634593not yet assessed
-
Do serum biomarkers really measure breast cancerBioMed Central eBooks · 2009not yet assessed
-
Abstract #4399: Role of eotaxin-1 signaling in ovarian cancerCancer Research · 2009not yet assessed
-
QS119. A Germline Polymorphism in SIPA1 Does Not Predict Metastatic Potential in Breast Cancer ↗Journal of Surgical Research · 2009not yet assessed
-
Role of Eotaxin-1Signaling in Ovarian Cancer2009not yet assessed
-
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression ↗Journal of Clinical Oncology · 2008 · PMID 18612148not yet assessed
-
Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors ↗PLoS ONE · 2008 · PMID 18167534not yet assessed
-
ISG15 as a novel tumor biomarker for drug sensitivity ↗Molecular Cancer Therapeutics · 2008 · PMID 18566215not yet assessed
-
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer ↗Breast Cancer Research · 2008 · PMID 18474099not yet assessed
-
Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup ↗Cancer Epidemiology Biomarkers & Prevention · 2008 · PMID 18349276not yet assessed
-
Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction ↗PLoS ONE · 2008 · PMID 18197258not yet assessed
-
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors ↗Cancer Chemotherapy and Pharmacology · 2008 · PMID 18365198not yet assessed
-
Erratum: Corrigendum: Genomic signatures to guide the use of chemotherapeutics ↗Nature Medicine · 2008not yet assessed
-
Genomic signatures to guide the use of chemotherapeutics (vol 12, Pg 1294, 2006)2008not yet assessed
-
Peripheral blood cell signatures as novel breast cancer biomarkersClinical Cancer Research · 2008not yet assessed
-
A clinicogenomic model to predict lymph node metastasis in breast cancer ↗Journal of the American College of Surgeons · 2008not yet assessed
-
QS289. RGS5 Modulates Human Calcium Sensing Receptor and Is Variably Expressed in Primary Hyperparathyroidism ↗Journal of Surgical Research · 2008not yet assessed
-
An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer ↗Journal of Clinical Oncology · 2007 · PMID 17290060not yet assessed
-
Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer ↗Cancer Research · 2007 · PMID 17409409not yet assessed
-
Trinucleotide Repeat Polymorphisms in the Androgen Receptor Gene and Risk of Ovarian Cancer ↗Cancer Epidemiology Biomarkers & Prevention · 2007 · PMID 17372242not yet assessed
-
Isogenic Normal Basal and Luminal Mammary Epithelial Isolated by a Novel Method Show a Differential Response to Ionizing Radiation ↗Cancer Research · 2007 · PMID 17409405not yet assessed
-
Regulation of the metastasis suppressor gene MKK4 in ovarian cancer ↗Gynecologic Oncology · 2007 · PMID 17276500not yet assessed
-
Pooling of Case Specimens to Create Standard Serum Sets for Screening Cancer Biomarkers ↗Cancer Epidemiology Biomarkers & Prevention · 2007 · PMID 17301268not yet assessed
-
Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites. ↗PubMed · 2007 · PMID 17668637not yet assessed
-
not yet assessed
-
Molecular signatures characterize early stage breast cancer arising in young women and have prognostic and therapeutic implications independent of ER status ↗Journal of Clinical Oncology · 2007not yet assessed
-
Erratum: Corrigenda: Genomic signatures to guide the use of chemotherapeutics ↗Nature Medicine · 2007not yet assessed
-
Development and evaluation of molecular signatures for predicting the efficacy of therapeutics in PI3KCA mutated breast cancer tumors.Clinical Cancer Research · 2007not yet assessed
-
Hypermethylation of the MAL gene promoter in breast cancerCancer Research · 2007not yet assessed
-
Genomic signatures to guide the use of chemotherapeutics ↗Nature Medicine · 2006 · PMID 17057710not yet assessed
-
The type III TGF-β receptor suppresses breast cancer progression ↗Journal of Clinical Investigation · 2006 · PMID 17160136not yet assessed
-
Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression ↗Cancer Research · 2006 · PMID 16618726not yet assessed
-
Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer ↗Molecular Cancer Research · 2006 · PMID 16603642not yet assessed
-
Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy ↗Clinical Cancer Research · 2006 · PMID 16467094not yet assessed
-
Enhanced Sensitivity to Cytochrome c–Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells ↗Cancer Research · 2006 · PMID 16489023not yet assessed
-
High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels ↗International Journal of Gynecological Cancer · 2006 · PMID 16884361not yet assessed
-
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study ↗Gynecologic Oncology · 2006 · PMID 16551475not yet assessed
-
Gene expression associated with sestimibi uptake in primary parathyroid adenomas ↗Journal of Surgical Research · 2006not yet assessed
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies ↗Nature · 2005 · PMID 16273092not yet assessed
-
Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers ↗Clinical Cancer Research · 2005 · PMID 15897565not yet assessed
-
Associations Between Drug Metabolism Genotype, Chemotherapy Pharmacokinetics, and Overall Survival in Patients With Breast Cancer ↗Journal of Clinical Oncology · 2005 · PMID 16087946not yet assessed
-
Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer ↗Oncogene · 2005 · PMID 15735726not yet assessed
-
Analgesic Drug Use and Risk of Ovarian Cancer ↗Epidemiology · 2005 · PMID 16357602not yet assessed
-
IGF1 (CA)19 Repeat and IGFBP3 -202 A/C Genotypes and the Risk of Prostate Cancer in Black and White Men ↗Cancer Epidemiology Biomarkers & Prevention · 2005 · PMID 15734965not yet assessed
-
Evaluation of expression based markers for the detection of breast cancer cells ↗Breast Cancer Research and Treatment · 2005 · PMID 16319979not yet assessed
-
Transforming growth factor β receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk ↗Gynecologic Oncology · 2005 · PMID 15863158not yet assessed
-
The DEAD box helicase DDX6 physically interacts with the tumor suppressor BRCA1 ↗Journal of the American College of Surgeons · 2005not yet assessed
-
Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression ↗Molecular and Cellular Biology · 2004 · PMID 15082792not yet assessed
-
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays ↗American Journal of Obstetrics and Gynecology · 2004 · PMID 15118612not yet assessed
-
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer ↗Gynecologic Oncology · 2004 · PMID 15661221not yet assessed
-
Cell Cycle Progression in G 1 and S Phases Is CCR4 Dependent following Ionizing Radiation or Replication Stress in Saccharomyces cerevisiae ↗Eukaryotic Cell · 2004 · PMID 15075273not yet assessed
-
Progesterone Receptor Promoter +331A Polymorphism is Associated with a Reduced Risk of Endometrioid and Clear Cell Ovarian Cancers ↗Cancer Epidemiology Biomarkers & Prevention · 2004 · PMID 15598772not yet assessed
-
Treatment of Intracerebral Neoplasia and Neoplastic Meningitis with Regional Delivery of Oncolytic Recombinant Poliovirus ↗Clinical Cancer Research · 2004 · PMID 15269159not yet assessed
-
TAFII70 Isoform-Specific Growth Suppression Correlates With Its Ability to Complex With the GADD45a Protein ↗Molecular Cancer Research · 2004 · PMID 15328371not yet assessed
-
Estrogen receptor α (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast ↗Genes Chromosomes and Cancer · 2004 · PMID 15034868not yet assessed
-
Gene expression signature characterizing cyclin E protein overexpression in primary breast tumors ↗Journal of the American College of Surgeons · 2004not yet assessed
-
025 Relationship Between Polymorphisms in The Progesterone and Type I TGF-Beta Receptors and Ovarian Cancer Risk ↗International Journal of Gynecological Cancer · 2004not yet assessed
-
009 Microarray Analysis Defines Patterns of Gene Expression Characteristic of Long-Term Survival in Advanced Stage Serous Ovarian Cancers ↗International Journal of Gynecological Cancer · 2004not yet assessed
-
Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene ↗Cancer Cell · 2003 · PMID 12676587not yet assessed
-
Molecular markers in ductal carcinoma in situ of the breast. ↗PubMed · 2003 · PMID 12651909not yet assessed
-
A neural survival factor is a candidate oncogene in breast cancer ↗Proceedings of the National Academy of Sciences · 2003 · PMID 12953101not yet assessed
-
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. ↗PubMed · 2003 · PMID 14555511not yet assessed
-
Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers ↗Journal of the Society for Gynecologic Investigation · 2003 · PMID 14706684not yet assessed
-
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival. ↗PubMed · 2003 · PMID 12576447not yet assessed
-
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. ↗PubMed · 2003 · PMID 12646513not yet assessed
-
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast1 ↗Journal of Surgical Research · 2003 · PMID 12943812not yet assessed
-
Null Results in Brief No Relationship between Ovarian Cancer Risk and Progesterone Receptor Gene Polymorphism in a Population-based, Case-Control Study in North Carolina 12003not yet assessed
-
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 ↗Nature Genetics · 2002 · PMID 12021784not yet assessed
-
Prediction and uncertainty in the analysis of gene expression profiles. ↗PubMed · 2002 · PMID 12542420not yet assessed
-
BRCA2 Monoclonal Antibodies React with Differentiating Epithelium ↗Hybridoma and Hybridomics · 2002 · PMID 12193279not yet assessed
-
Predicting the clinical status of human breast cancer by using gene expression profiles ↗Proceedings of the National Academy of Sciences · 2001 · PMID 11562467not yet assessed
-
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer ↗Oncogene · 2001 · PMID 11423985not yet assessed
-
A SAGE (serial analysis of gene expression) view of breast tumor progression. ↗PubMed · 2001 · PMID 11479200not yet assessed
-
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. ↗PubMed · 2001 · PMID 11289162not yet assessed
-
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells ↗Proceedings of the National Academy of Sciences · 2001 · PMID 11481438not yet assessed
-
Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma ↗Cancer · 2001 · PMID 11413513not yet assessed
-
Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones ↗Journal of the Society for Gynecologic Investigation · 2001 · PMID 11336882not yet assessed
-
Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations ↗Gynecologic Oncology · 2001 · PMID 11733961not yet assessed
-
Prognostic significance of the number of lymph nodes examined in patients with lymph node‐negative breast carcinoma ↗Cancer · 2001not yet assessed
-
Compromised HOXA5 function can limit p53 expression in human breast tumours ↗Nature · 2000 · PMID 10879542not yet assessed
-
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer ↗Proceedings of the National Academy of Sciences · 2000 · PMID 10811911not yet assessed
-
Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. ↗PubMed · 2000 · PMID 10714766not yet assessed
-
Estrogen-induced mitogenesis of MCF-7 cells does not require the induction of mitogen-activated protein kinase activity ↗The Journal of Steroid Biochemistry and Molecular Biology · 2000 · PMID 11179904not yet assessed
-
not yet assessed
-
Isolation and initial characterization of the BRCA2 promoter ↗Oncogene · 1999 · PMID 10557089not yet assessed
-
Telomerase Activity and Prognosis in Primary Breast Cancers ↗Journal of Clinical Oncology · 1999 · PMID 10506602not yet assessed
-
Managing hereditary ovarian cancer risk ↗Cancer · 1999 · PMID 10630177not yet assessed
-
Bcl10 is not a target for frequent mutation in human carcinomas ↗British Journal of Cancer · 1999 · PMID 10408401not yet assessed
-
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR) ↗Cancer Chemotherapy and Pharmacology · 1999 · PMID 9923544not yet assessed
-
Managing hereditary ovarian cancer risk ↗Cancer · 1999not yet assessed
-
Bcl10 is not a target for frequent mutation in human carcinomas ↗British Journal of Cancer · 1999not yet assessed
-
"Los ángeles mudos": la renovación poética al servicio de la temática albertianaAcademica-e (Universidad Pública de Navarra) · 1999not yet assessed
-
Frequency of germline and somatic BRCA1 mutations in ovarian cancer. ↗PubMed · 1998 · PMID 9796975not yet assessed
-
Complex response of breast epithelial cell lines to topoisomerase inhibitors. ↗PubMed · 1998 · PMID 9713486not yet assessed
-
Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma ↗Cancer · 1998 · PMID 9486576not yet assessed
-
Repression of Interleukin-2 mRNA Translation in Primary Human Breast Carcinoma Tumor-Infiltrating Lymphocytes ↗Cellular Immunology · 1998 · PMID 9878115not yet assessed
-
Familial Breast-Ovarian Cancer Syndromes ↗Clinical Obstetrics & Gynecology · 1998 · PMID 9504233not yet assessed
-
Aberrant Splicing of the TSG101 Tumor Suppressor Gene in Human Breast and Ovarian Cancers ↗Journal of the Society for Gynecologic Investigation · 1998not yet assessed
-
Artificial neural networks improve the accuracy of cancer survival prediction ↗Cancer · 1997 · PMID 9024725not yet assessed
-
BRCA2 mutations in primary breast and ovarian cancers ↗Nature Genetics · 1996 · PMID 8640235not yet assessed
-
Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. ↗PubMed · 1996 · PMID 9816335not yet assessed
-
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. ↗PubMed · 1996 · PMID 8780884not yet assessed
-
Cell cycle control of BRCA2. ↗PubMed · 1996 · PMID 8840967not yet assessed
-
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer ↗Molecular Carcinogenesis · 1996 · PMID 8944076not yet assessed
-
p53 overexpression in advanced-stage endometrial adenocarcinoma ↗American Journal of Obstetrics and Gynecology · 1996 · PMID 8942496not yet assessed
-
Inhibition of the erbB-2 Tyrosine Kinase Receptor in Breast Cancer Cells by Phosphoromonothioate and Phosphorodithioate Antisense Oligonucleotides ↗Nucleic Acids Research · 1996 · PMID 8948649not yet assessed
-
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer ↗Molecular Carcinogenesis · 1996not yet assessed
-
not yet assessed
-
Identification of a New Subclass of Alu DNA Repeats Which Can Function as Estrogen Receptor-dependent Transcriptional Enhancers ↗Journal of Biological Chemistry · 1995 · PMID 7559405not yet assessed
-
p53 in Human Cancer ↗Humana Press eBooks · 1995not yet assessed
-
Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. ↗Proceedings of the National Academy of Sciences · 1995 · PMID 7667291not yet assessed
-
Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer ↗Breast Cancer Research and Treatment · 1995 · PMID 7579490not yet assessed
-
Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma. ↗PubMed · 1995 · PMID 7802567not yet assessed
-
Determination of Proliferation Index By MIB-1 Immunostaining in Early Stage Breast Cancer Using Quantitative Image Analysis ↗The Breast Journal · 1995not yet assessed
-
The p53 tumor suppressor gene frequently is altered in gynecologic cancers ↗American Journal of Obstetrics and Gynecology · 1994 · PMID 8296829not yet assessed
-
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. ↗PubMed · 1994 · PMID 7696178not yet assessed
-
Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer ↗Annals of Surgery · 1994 · PMID 7909221not yet assessed
-
Epithelial Cells Are an Important Source of Tenascin in Normal and Malignant Human Breast Tissue ↗Experimental Cell Research · 1994 · PMID 7507849not yet assessed
-
The p53 tumor suppressor gene frequently is altered in gynecologic cancers ↗American Journal of Obstetrics and Gynecology · 1994not yet assessed
-
The p53 tumor suppressor gene frequently is altered in gynecologic cancers ↗International Journal of Gynecology & Obstetrics · 1994not yet assessed
-
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer ↗JNCI Journal of the National Cancer Institute · 1993 · PMID 8360934not yet assessed
-
Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. ↗PubMed · 1993 · PMID 8469448not yet assessed
-
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias ↗American Journal of Obstetrics and Gynecology · 1993 · PMID 8372881not yet assessed
-
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. ↗PubMed · 1992 · PMID 1568230not yet assessed
-
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. ↗PubMed · 1992 · PMID 1741160not yet assessed
-
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. ↗Journal of Histochemistry & Cytochemistry · 1992 · PMID 1607637not yet assessed
-
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. ↗Proceedings of the National Academy of Sciences · 1992 · PMID 1373500not yet assessed
-
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells ↗American Journal of Obstetrics and Gynecology · 1992 · PMID 1361720not yet assessed
-
Overexpression and mutation of the p53 oncogene in endometrial adenocarcinoma ↗Gynecologic Oncology · 1992not yet assessed
-
Relative promoter activity in human mammary epithelial cells assayed by transient expression ↗In Vitro Cellular & Developmental Biology - Animal · 1992 · PMID 1483964not yet assessed
-
Overexpression and mutation of p53 in epithelial ovarian cancer. ↗PubMed · 1991 · PMID 2032235not yet assessed
-
Genetic basis for p53 overexpression in human breast cancer. ↗Proceedings of the National Academy of Sciences · 1991 · PMID 2052583not yet assessed
-
Maintenance of p53 alterations throughout breast cancer progression. ↗PubMed · 1991 · PMID 1850660not yet assessed
-
Relation between p53 overexpression and established prognostic factors in breast cancer. ↗PubMed · 1991 · PMID 1858036not yet assessed
-
p53 alterations in all stages of breast cancer ↗Journal of Surgical Oncology · 1991 · PMID 1745051not yet assessed
-
Proliferation index in various stages of breast cancer determined by ki‐67 immunostaining ↗Journal of Surgical Oncology · 1991 · PMID 1716331not yet assessed
-
Absence of the p53 Tumor Suppressor Protein in Neuroepithelioma-Derived Cell LinesJournal of Bioresource Management · 1991not yet assessed
-
Increased erbB-2 gene copies and expression in multiple stages of breast cancer. ↗PubMed · 1990 · PMID 2208136not yet assessed
-
p53 Expression in NeuroblastomaCORE Scholar (Wright State University) · 1990not yet assessed
-
Process monitoring in milling by pattern recognition ↗Mechanical Systems and Signal Processing · 1989not yet assessed
-
Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen ↗Journal of Virology · 1989 · PMID 2642978not yet assessed
-
Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas ↗Journal of Neuroscience Research · 1989 · PMID 2478718not yet assessed
-
Replication of the murine cytomegalovirus genome: Structure and role of the termini in the generation and cleavage of concatenates ↗Virology · 1988 · PMID 2827390not yet assessed
-
The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice. ↗PubMed · 1988 · PMID 2851142not yet assessed
-
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice ↗Journal of Virology · 1987 · PMID 3033329not yet assessed
-
Fusion of the termini of the murine cytomegalovirus genome after infection ↗Journal of Virology · 1984 · PMID 6090700not yet assessed
-
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain) ↗Virology · 1983 · PMID 6310888not yet assessed
-
Transcription in mouse embryo cells permissively infected by murine cytomegalovirus ↗Virology · 1983 · PMID 6196913not yet assessed
-
Mycobacterial Disease in Man and Animals [ Abridged ] ↗Proceedings of the Royal Society of Medicine · 1964 · PMID 14194026not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Marks J” paper on PubMed ↗